Connecting to LinkedIn...

W1siziisijiwmtuvmdqvmtuvmdgvntqvmzgvnzi1l01ptlrbu0hfqkxpr19vtljftkrfukvex0lnqudfx3jlc2l6zwrfyw5kx3jlbmrlcmvklmpwzyjdlfsiccisinrodw1iiiwimtkymhgxmjuwiyjdxq

Blog

CHMP backs use of Avastin for hard-to-treat ovarian cancer

27/06/2014 by

W1siziisijiwmtqvmtavmjgvmtuvmzuvndavnte0l2zpbguixsxbinailcj0ahvtyiisijywmhg0mdbcdtawm2uixv0

Advisors to the European Medicines Agency have backed Roche’s blockbuster Avastin for the most difficult to treat form of ovarian cancer.

The EMA’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission approve the use of Avastin (bevacizumab) in combination with chemotherapy as a treatment for women with ovarian cancer that is resistant to platinum-containing chemotherapy. The positive opinion is based on a Phase III study showing that the addition of Avastin to chemotherapy reduced the risk of disease worsening or death by 62%.

The big-selling drug is already approved in Europe for ovarian cancer, among many other cancers, such as breast, colorectal, non-small cell lung and kidney. Of the 230,000 women diagnosed worldwide each year many will have advanced ovarian cancer that will return after initial treatment, Roche noted, and chief medical officer Sandra Horning noted that women with platinum-resistant ovarian cancer “have limited medicines available for their difficult disease”.

This article has been extracted from http://www.pharmatimes.com, please click on this link to read the article in full http://www.pharmatimes.com/Article/14-06-27/CHMP_backs_use_of_Avastin_for_hard-to-treat_ovarian_cancer.aspx

Montash is a multi-award winning, global IT recruitment firm. Specialising in permanent and contract positions across mid-senior appointments which cover a wide range of industry sectors and IT functions, including:

ERP, BI & Data, Information Security, IT Architecture & Strategy, Scientific Technologies, Demand IT and Business Engagement, Digital and E-commerce, Infrastructure and Service Delivery, Project and Programme Delivery.

With offices based in London, Montash has completed assignments in over 30 countries and has appointed technical professionals from board level to senior and mid-management in permanent and contract roles.

comments powered by Disqus

Social Stream

Latest News

W1siziisijiwmtcvmdgvmtqvmtmvmjcvmjgvnja2l2nsb3rozxmuanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

In Her Shoes... From Market Stall to Recruitment

2017-08-14 14:00:00 +0100

From the melee of the market stall to placing candidates in high-flying IT roles, life's always on the up from market-trader-turned-recruiter, Lois Hinken (22). She took the time to talk to us about how her experience in the cut throat world of the market has helped her in the world of global talent acquisition. As a 360 recruitment consultant for Montash, her negotiation skills and "go get it" attitude have helped her thrive. "I started working on the ...

W1siziisijiwmtcvmdgvmdcvmtmvmtcvntqvnze3l1vudgl0bgvkigrlc2lnbiaomikuanbnil0swyjwiiwidgh1bwiilcizodb4mtawiyjdxq

Will AI Cost Us Our Humanity?

2017-08-07 15:00:00 +0100

As technology evolves, artificial intelligence is becoming increasingly mainstream, and it will inevitably start to impact the way we interact. On the one hand, AI has the potential to solve a variety of problems and streamline our lives and our work. But will this come at the cost of the all-important human touch? A foreshadowing statistic claims that by 2020, 85% of client interactions will be managed without a human[1]. But can there really be an alg...